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ABSTRACT
Sera from 27 patients with mite-sensitive allergic rhinitis, 
without atopic dermatitis and bronchial asthma, were exam-
ined for anti-Der f I and anti-Der f II IgE antibody contents by 
enzyme-linked immunosorbent assay (ELISA). Anti-Der f I
and anti-Der f II IgE antibody levels were 14.78±1.34 and
32.68±0.88ng/mL (mean±SEM), respectively. The anti-
Der f II IgE antibody was predominant over the anti-Der f 
IgE antibody in these patients.
 In comparison with the results of a previous study the pres-
ent study indicates that the ratio between serum anti-Der f I 
and II IgE antibodies in patients with allergic rhinitis indicated 
the same pattern as in that of patients with bronchial asthma, 
while the inverse was the case in patients with atopic 
dermatitis.
 These results indicate that immunological features and 
major allergen molecules could be different in different 
atopic diseases. At present it is not clear where this difference 
comes from, but the route of immunological sensitization 
(via respiratory tract vs via skin) might result in the difference.
Key words: Der f I, Der Ill, IgE antibody, major allergen, 
mite.
INTRODUCTION
Allergy to house dust is an important cause for atopic diseases 
such as allergic rhinitis, bronchial asthma and atopic dermatitis 
in many countries. It has been well established that two different 
species of mite, Dermatophagoides pteronyssinus and Derma-
tophagoides farinae, are the major sources of allergen in house 
dust.1-4
 The purification of mite allergen has been attempted by many 
investigators. At present, there is some general consent that the 
major allergens purified from both species may be grouped into 
two main groups of mite allergen, one group with a molecular 
weight of about 25kDa and another with a molecular weight of 
about 15kDa. According to the new allergen nomenclature sys-
tem,5 the major allergens for the house dust mites are to be des-
ignated as Der p I and Der f I for the large molecular-weight 
allergens, while the low molecular-weight allergens are called 
Der p II and Der f II, all isolated from either of the species.
 Anti-mite IgE antibodies have been routinely measured in 
clinical practice for the management of mite-sensitive atopic 
patients, however the allergen preparations used for the assay 
were crude extracts of mite body or mite culture. This limitation 
prevented detailed analysis of anti-mite IgE antibodies in differ-
ent atopic diseases. Recent progress in mite allergen research 
enabled us to analyze the anti-mite IgE antibodies directed to 
different allergen molecules in different atopic diseases. 
However, there have been few reports on anti-Der f I and anti-
Der f II IgE antibodies in patients with allergic rhinitis. In this 
study, anti-Der f I and anti-Der f II IgE antibody contents were 
examined in patients with allergic rhinitis.
METHODS
Subjects
Twenty-seven patients with perennial mite-sensitive allergic 
rhinitis, without bronchial asthma and atopic dermatitis, were 
subjected to the study. The group was composed of 18 males 
and 9 females aged between 15 and 55 years (mean age 
31.1).
Preparation of crude mite extract of D. farinae
Dermatophagoides farinae was defatted with ether, 20mL of 
phosphate-buffered saline (2mmol/L, pH 7.4) was added to 1g
of defatted mite and the mixture was rotated for 48h at 4℃.
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Preparation of Der f I and II
Isolation of Der f I was attempted by a method described previ-
ously6 and isolation of Der f II by the method reported by 
Yasueda et al.,7 with slight modifications. The columna such as 
CM-cellulose (CM-52, Whatman, Springfield Mill, Kent, UK) 
and Sephadex G-75 (Pharmacia, Uppsala, Sweden) were used 
when the isolation of Der f II was carried out. These were differ-
ent from those of Yasueda et al.
Enzyme-linked immunosorbent assay for anti-Der f 
I and II IgE antibodies
For anti-Der f I and II IgE antibody measurements, micro-titer 
plates (Immulon 2; Dynatech Laboratories, Chantilly, VA, USA)
were incubated with 100μL/well of 10μg/mL Der f I or 50
μg/mL of Derf II in 0.1mol/L corbonate buffer (pH 9.6) overnight
in the cold in a humidified box. After three washes with phos-
phate-buffered saline/Tween, protein-binding sites of the wells
were blocked with 100μL of Block Ace (Yukijirusi, Tokyo, Japan).
Diluted 100μL serum samples (1/2 dilution for IgE) were added
to the wells. After incubation for 1 h at room temperature, the 
serum samples were removed and washed three times. Then 100
μL of 1/3000-diluted biotin-labeled affinity-purified goat antihu-
man IgE fragment (Tago, Burlingame, CA, USA) was added to 
each well and incubated at room temperature for 1h. After three
washes, 100μL of 1/4000-diluted peroxidase-avidin D (Vector
Laboratories, Burlingame, CA, USA) was added to each well and 
incubated further for 1h. The wells were then washed three times
with phosphate-buffered saline and 100μL of o-phenylenedi-
amine dihydrochlorine (Sigma Chemicals, St Louis, MO, USA)
substrate solution was added, followed by the addition of 100μL
of 4N sulfuric acid to terminate the reaction. Absorbance at 490 
nm was read by an automatic ELISA reader (model MTP-32; 
Corona Electric, Ibaragi, Japan). A preparation of atopic serum 
which contained 526ng/mL of anti-Der f I and 139ng/mL of anti-
Der f II IgE antibodies was employed as a standard. Absolute 
amount of IgE antibody was calculated on the intensity of coloring 
reaction by plotting on the standard curve prepared using a 
known amount of PS IgE myeloma protein.
Statistical analysis
Data were analyzed by applying paired sample t-test. P values 
<0.05 were considered statistically significant.
RESULTS
Anti-Der f I and anti-Der f II IgE antibody levels in the sera of the 
patients with allergic rhinitis are shown in Fig. 1. Anti-Der f I and
II IgE antibody levels were 14.78±1.34ng/mL, 32.68±0.88
ng/mL (mean±SEM), respedively. The ratio between serum
anti-Der f I and II IgE antbodies (anti-Der f I: II ratio) was 0.45±
0.66 (Fig. 2). Anti-Der f II IgE antibody level was significantly 
higher than anti-Der f I IgE antibody level (P<0.01).
Fig. 1 Anti-Der f I and II IgE antibody levels in the sera of patients with 
allergic rhinitis.
Fig. 2 The ratio between serum anti-Der f I and II IgE antibodies in the 
patients with allergic rhinitis.
DISCUSSION
Since the discovery of the house dust allergen for atopic dis-
eases around 1920, many investigators have sought its origin.
DER F I AND II IN ALLERGIC RHINITIS 197
In 1967, Voorhorst et al. found that the house dust allergen 
content assessed by skin tests correlated well with the number of 
Dermatophagoides mites in house dust.2 In 1968, Miyamoto et 
al. observed that IgE antibody titers against house dust and 
Dermatophagoides mite correlated very well.3 Based on such 
findings, the importance of mite allergen in house dust allergy 
has been established gradually.
 Subsequently, many investigators attempted the purification 
of mite allergen, but it took more than 12 years until Chapman 
and Platts-Mills reported purified antigen P1 in 1980.8 The diffi-
culty of mite allergen research mainly derives from the multipli-
city of mite allergens. Recently, several groups of studies have 
described the characterization and the method of isolation of 
the major allergen from Dermatophagoides pteronyssinus and 
Dermatophagoides farinae (Table 1).8-18
 It was known that mite fecal particles as well as mite bodies 
were important sources of mite allergen, and it was speculated 
that a digestive enzyme secreted from the gastrointestinal tract 
may be one of the mite allergens. Chua et al. carried out 
sequence analyses of the Der p I cDNA clone and demonstrated 
the similarity of their amino acid sequences between Der p I and 
a group of cysteine proteases such as papain and cathepsin B.19
 Ando et al. tried to detect, purify and characterize a cysteine 
protease in the crude extract of D. farinae.6 According to their 
findings, comparison of the purified cysteine protease extract 
with purified Der f I led them to conclude that Der f I is actually 
a cysteine protease itself. On the other hand, recent investiga-
tions revealed that Der f II allergen is a protein derived from 
mite body composed of 129 amino acids containing six cys-
teine residues.20 The predicted Der f II amino acid sequence has 
no potential N-glycosylation sites.
 The detection of these major allergens enabled us to analyze 
the anti-mite IgE antibodies directed to different allergen mole-
cules in different atopic diseases. In a previous study, sera from 
23 patients with mite-sensitive bronchial asthma without atopic
d rmatitis and from 19 patients with atopic dermatitis without 
bronchial asthma, were examined for anti-Der f l and anti-Der f 
II IgE antibody contents.21 The ratio between serum anti-Der f I 
and II IgE antibodies (anti-Der f I: II) was significantly higher 
(P<0.05) in atopic dermatitis than in bronchial asthma patients.
The mean (±SEM) I: II ratio (85.17±2.01) was significantly
higher than 1.0 in atopic dermatitis patients, while it was 0.93
±0.16 in bronchial asthma patients. The results of this study of
patients with allergic rhinitis without atopic dermatitis and 
bronchial asthma showed that the anti-Der f II IgE antibody was 
predominant over the anti-Der f I IgE antibody. That is to say, the 
data in this study on the ratio between serum anti-Der f I and II 
IgE a tibodies in patients with allergic rhinitis indicated the 
same pattern as in that of patients with bronchial asthma, while 
the inverse was the case in patients with atopic dermatitis as 
reported in a previous study.21
 In comparison with the results of the previous study, the pres-
ent study indicates that the anti-Der f I: II ratio is lower in the
case of patients with allergic rhinitis (0.45±0.66) than in the
cas  of patients with bronchial asthma (0.93±0.16). These
results indicate that immunological features and major allergen 
molecules could be different in different atopic diseases.
 Thompson et al. also measured the IgE antibodies to two 
major allergens from D. pteronyssinus, Der p I and Der p II, 
among children with bronchial asthma, atopic dermatitis and 
allergic rhinitis, and reported that the anti-Derp I IgE antibody is 
predominant among the bronchial asthma group and the anti-
Derp II IgE antibody is predominant in the atopic dermatitis and 
allergic rhinitis groups.22,23
 The results of bronchial asthma and atopic dermatitis were 
contrary to the results of our previous study.21 However, the 
result on allergic rhinitis was consistent with the result of the 
present study. The reason for the inconsistency in results of 
the f r er study is not clear, however, it could be related to the 
fac  that the subjects Thompson et al.22,23 studied were children;
Table 1. Major allergens of mite
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the species of mite was D. pteronyssinus instead of D. farinae; 
the purification method of Der I and II was not the same as the 
method of our study; and the methods of measurement of IgE 
antibody were western blotting method and BAST method, 
which were different from our ELISA method. In the reports of 
Thompson et al., only the pediatric cases were studied. 
Therefore, if we consider the matter of allergy march, the differ-
ences in IgE antibody levels between the group I and group II 
allergens may be attributed to aging. In order to clarify the 
inconsistency, comparative studies on IgE antibody levels be-
tween Der p and Der f may be necessary using the same sub-
jects and method of measurement.
 It is also not clear why the dominancy of IgE antibody to Der f 
and II differs among the disease group. According to the report 
of Sakaguchi et al., it could not be due to the difference in the 
amount of antigen of Der f I and II in the house dust.24Therefore, 
the differences in anti-Der f I and II IgE antibody levels may be 
related to the strength in immunogenicity and antigenicity of the 
Der f I and II allergens when the antigen is inhaled as in the case 
of the bronchial asthma, in the same manner as allergic rhinitis.
 On the other hand, the defence wall of the skin is more rigid 
than the mucous membrane of the respiratory, tract against the 
invasion of foreign substances. Although invasion of protein 
antigen is usually difficult, the invasion of mite antigen in the 
skin lesion was proved in the patients with atopic dermatitis. 
Therefore, the route through the skin could not be negated.25 
Further, another reason for the higher anti-Der f I IgE antibody 
levels compared to the levels of Der f II may be the ease with 
which invasion by Der f I of the skin occurs due to its protease 
activity, but detailed explanation is not yet clarified. It is unclear 
whether the local `sites where antigen invades relate to the dif-
ference of interaction between the antigen and B cell.
REFERENCES
1 Voorhorst R, Spieksma-Boezeman MIA, Spieksma FTM. Is a mite 
  (Dermatophagoides sp.) the producer of the house dust allergen? 
  Allergie and Asthma 1964; 10: 329-34.
2 Voorhorst R, Spieksma FTM, Varekamp H, Leupen MJ, Lyklema 
  AW. The house-mite (Dermatophagoides pteronyssinus) and the 
   allergens it produces. Identity with the house-dust allergen. J. 
  Allergy 1967; 39: 325-39.
3 Miyamoto T, Oshima S, Ishizaki T, Sato S. Allergenic identity 
   between the common floor mite (Dermatophagoides farinae 
   Hughes, 1961) and house dust as a causative antigen in 
  bronchial asthma. J. Allergy 1968; 42: 14-28.
4 Maunsell K, Wraith DG, Cunnington AM. Mite and house-dust 
  allergy in bronchial asthma. Lancet 1968; 1: 1267-70.
5 Marsh DG, Goodfriend L, King TP, Lowenstein H, Platts-Mills TAE. 
  Allergen nomenclature. Bull. World Health Organ. 1986; 64: 
  767-70.
6 Ando T, Ino Y, Haida M et al. Isolation of cysteine protease in the 
   crude mite extract, Dermatophagoides farinae. Int. Arch. Allergy 
  Immunol. 1991; 96: 199-205.
7 Yasueda H, Mita H, Yui Y, Shida T. Isolation and characterization 
   of two allergens from Dermatophagoides farinae. Int. Arch. Allergy 
  Immunol. 1986; 81: 214-23.
8 Chapman MD, Platts-Mills TAE. Purification and characterization 
   of the major allergen from Dermatophagoides pteronyssinus anti-
   gen P1. J. Immunol. 1980; 125: 587-92.
9 Stewart GA. Isolation and characterization of the allergen Dpt 12 
   from Dermatophagoides pteronyssinus by chromatofocusing. Int. 
  Arch. Allergy Immunol. 1982; 69: 224-30.
10 Lind P Purification and partial characterization of two malor aller-
    gens from the house dust mite Dermatophagoides pteronyssinus. 
   J. Allergy Clin. Immunol. 1985; 76: 753-61.
11 Yasueda H, Mita H, Yui Y, Shida T. Comparative analysis of physic-
    ochemical and immunochemical properties of the two major aller-
    gens from Dermatophagoides pteronyssinus and the 
   corresponding allergens from Dermatophagoides farinae. Int. 
   Arch. Allergy Immunol. 1989; 88: 402-7.
12 Dandeu JP, Le Mao J, Lux M, Rabillon J, Davis B. Antigen and aller-
   gens in Dermatophagoides farinae mite. II. Purification of Agll, a 
   major allergen in Dermatophagoides farinae. Immunology 1982; 
   46: 679-87.
13 Lind P Demonstration of close physicochemical similarity and par-
   tial immunochemical identity between the major allergen, Dp42, 
    of the house dust mite, D. pteronyssinus and corresponding anti-
   gens of D. farinae (Df6) and D. microceras (Dm6). Int. Arch. 
   Allergy Immunol. 1986; 79: 60-5.
14 Yasueda H, Mita H, Yui Y, Shida T. Isolation and characterization 
    of two allergens from Dermatophagoides farinae. Int. Arch. Allergy 
   Immunol. 1986; 81: 214-23.
15 Heymann PW, Chapman MD, Platts-Mills TAE. Antigen Der f I from 
    the dust mite Dermatogoides farinae: structural comparison with 
   Der p I from Dermatophagoides pteronyssinus and epitope speci-
   ficity of murine IgG and human IgE antibodies. J. Immunol. 1986; 
   137: 2841-7.
16 Yamashita N, Haida M, Suko M, Okudaira H, Miyamoto T. 
   Allergens of the house dust mite Dermatophagoides farinae. II.     
Immunological characterization of four allergenic molecules. Int. 
   Arch. Allergy Immunol. 1989; 88: 173-5.
17 Haida M, Okudaira H, Ogita T et al. Allergens of the house dust 
   m te Dermatophagoides faringe-Immunochemical studies of 
   four allergenic fractions. J. Allergy Clin. Immunol. 1985; 75: 
   686-92.
18 Holck A, Dale S, Sletten K. Purification and characterization of a 
    major allergen from the house dust mite Dermatophagoides fari-
   nae. Allergy 1986; 41: 408-17.
19 Chua KY, Stewart GA, Thomas WR et al. Sequence analysis of 
    cDNA coding for a major house dust mite allergen, Der p I. J. Exp. 
   Med. 1988; 167: 175-82.
20 Yuuki T, Okumura Y, Ando T et al. Cloning and sequencing of 
    cDNAs corresponding to mite major allergen Der f II. Arerugi 
   (Japanese Journal of Allergology) 1990; 39: 557-61.
21 Matsuzaki G, Shu U, Ando T, Suko M, Ito K, Okudaira H. Anti-
   Dermatophagoides farinae group I and II IgE antibodies in atopic 
    p tients. Int. Arch. Allergy Immunol. 1992; 99: 463-5.
22 Carswell F, Thompson SJ. Percutaneous sensitization to house dust 
    mite may occur naturally in eczema. Int. Arch. Allergy Immunol. 
   1987; 82: 453-5.
23 Thompson SJ, Whitley HD, Naysmith JD, Carswell F. IgE antibodies 
    to D. pteronyssinus in atopic patients. Immunology 1988; 64: 
   311-14.
24 Sakaguchi M, Inoue S, Yasueda H, Irie T, Yoshizawa S, Shida T. 
    Measurement of allergens associated with dust mite allergy. Int. 
   Arch. Allergy Immunol. 1989; 90: 190-3.
25 Tanaka Y, Takenaka M, Matsunaga Yet al. High affinity IgE recep-
   tor (FccRI) expression on eosinophils infiltrating the lesions and 
    mite patch tested sites in atopic dermatitis. Arch. Dermatol. Res. 
   1995; 287: 712-17.
